Skip to main content

Center for Communicable Disease Dynamics

The Center for Communicable Disease Dynamics works to improve methods for infectious disease modeling and statistical analysis, quantify disease and intervention impact, engage with policymakers to enhance decision-making, and train the next generation of scientists.

Location

677 Huntington Avenue
Kresge Building, Suite 506
Boston, MA 02115

Affiliates

Alt=""

Alyssa Bilinski, PhD, is the Peterson Family Assistant Professor of Health Policy at Brown University School of Public Health in the Departments of Health Services, Policy & Practice and Biostatistics. Her research bridges simulation modeling and observational causal inference, synthesizing these approaches to support policy decision-making and identify interventions that can most efficiently improve population health and well-being, with a particular focus on applications in infectious disease and maternal health. Her work has been published in leading peer-reviewed journals, including the Journal of the American Medical Association, Proceedings of the National Academy of Sciences, and Annals of Internal Medicine, and covered by major news outlets, such as the New York TimesWall Street Journal, and Washington Post. She has also collaborated with state, local, and federal public health officials to help translate her research into practice and served as a committee member for the National Academies of Sciences, Engineering, and Medicine. Dr. Bilinski received a PhD in Health Policy (Evaluative Science & Statistics) and an AM in Statistics from the Harvard Graduate School of Arts and Sciences, an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine as a Marshall Scholar, and a BA from Yale College.

Headshot of Ted Cohen (Square)

Dr. Cohen is an infectious disease epidemiologist whose primary research focus is tuberculosis. He is particularly interested in understanding how drug-resistance and medical comorbidities such as HIV frustrate current efforts to control tuberculosis epidemics, with a goal of developing more effective approaches to limit the morbidity caused by this pathogen.